Similarly, exposure to TK-216, the clinical derivative of YK-4-279, reduced the interaction of ETS factors SPIB and SPI1 with these RNA helicases in B-cell lymphomas (34). The gene discussed is SPI1; the disease is B-cell non-Hodgkin lymphoma.